Express Scripts targets new migraine drugs to change U.S. pricing dynamic

LOS ANGELES (Reuters) - The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen Inc and other makers of new migraine medicines to try and fix it.

AstraZeneca flop a fresh blow to cancer immunotherapy combination

LONDON (Reuters) - The concept of combining two immunotherapy drugs to fight lung cancer - not so long ago one of the hottest ideas in cancer research - has suffered a fresh blow from the failure of an AstraZeneca clinical study.

UK bans Sanofi epilepsy drug without pregnancy prevention plan

LONDON (Reuters) - A Sanofi drug for epilepsy and bipolar disorder linked to thousands of birth defects has been banned in Britain for use in women or girls of child-bearing age, unless they are on a special pregnancy prevention program.

Ex-Roche scientist Reed to head Sanofi R&D as Zerhouni retires

(Reuters) - Sanofi said on Tuesday it had hired former Roche top scientist John Reed to head its research operations from July 1, when Elias Zerhouni retires from the French drugmaker.

FDA panel against higher dose of Lilly-Incyte arthritis drug

(Reuters) - An arthritis drug developed by Eli Lilly & Co and Incyte Corp should not be approved at a 4-milligram dose, advisers to the U.S. FDA voted on Monday, in a setback to the drugmakers that were counting on the treatment as a future blockbuster.

Wounded soldier gets world's first penis transplant in U.S. operation

(Reuters) - A soldier wounded by an improvised explosive device in Afghanistan has received the world's first complete penis and scrotum transplant, officials at Johns Hopkins Hospital in Baltimore said on Monday.

Trump delays drug pricing speech, no set date yet

WASHINGTON (Reuters) - U.S. President Donald Trump has postponed a speech on lowering prescription drug prices previously scheduled for Thursday to a date in the near future, the White House said on Sunday.

Magnetic fields in electric cars don't seem to cause pacemaker problems

(Reuters Health) - Electromagnetic fields produced by motors in electric cars don’t appear strong enough to interfere with implanted heart devices like pacemakers and defibrillators, a small German study suggests.

FDA declines to approve Pfizer biosimilar of Roche's cancer drug

(Reuters) - Pfizer Inc said on Monday U.S. regulators declined to approve the company's biosimilar of Roche's blockbuster treatment for breast cancer, Herceptin, and sought additional technical information.

Vaping tied to higher risk that teens will try marijuana

(Reuters Health) - Teens who use e-cigarettes may be twice as likely to smoke pot as their peers who never try vaping, a U.S. study suggests.

Related Videos

Banned in the UK: straws and cotton buds, maybe

Britain plans to ban the sale of plastic straws and other single use products and is pressing Commonwealth allies to also take action to tackle marine waste, the office of Britain's Prime Minister Theresa May said.

UK firm turns discarded gum into shoes, coffee cups, and combs

Chewing gum is a blight on city streets and takes a heavy toll on the environment, say its critics. But one woman in Britain is performing modern-day alchemy on it - Gumdrop founder Anna Bullus - as Amber Austin-Wright found out.
You might like...

Check out our Reuters News Now daily briefing for hand-picked stories from Reuters editors. It's all the news you need to start your day.

Subscribe here